MAZE
Maze Therapeutics, Inc.
26.30$
-0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -116.0% | – | – | – | – | – | – | – | – | |
| – | -2.8% | -2.7% | -10.1% | -7.7% | -10.5% | -3.0% | -5.1% | -12.0% | -12.6% | -11.0% | -11.9% | – | |
| – | +21.0% | -9.7% | -7.3% | +9.4% | +21.7% | +13.2% | +0.3% | +19.4% | +57.2% | +17.1% | +29.2% | – | |
| – | -333.4% | – | +875.5% | -315.4% | – | -238.2% | – | – | -112.6% | – | – | – | |
| – | +1,033.3% | +720.6% | -42.7% | -35.6% | +487.4% | -50.6% | +31.4% | -82.7% | -50.0% | +173.5% | +15.1% | – | |
| – | -1,233.3% | +720.6% | -42.7% | -35.6% | +487.4% | -50.6% | +31.4% | +16,918.6% | +54.6% | – | -2,147.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | +202,250.0% | +51.8% | -99.4% | -1,496.1% | – | +81.3% | -99.5% | +23,389.7% | -97.5% | +1,079.9% | +248.1% | – | |
| – | – | – | +16,667.9% | -117.6% | – | +106.7% | -130.6% | – | -344.2% | – | -59.3% | – | |
| – | – | – | – | -116.1% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.